Plan robustness evaluation strategies in whole-pelvic proton therapy for high-risk prostate cancer patients within a randomised clinical trial
CONCLUSION: The PRE strategy predicted the DRE scenarios for CTVp and rectum. CTVe, bladder, and bowel showed more complex anatomical variations than simulated by the PRE isocenter shift. Both original and recalculated nominal treatment plans showed robust treatment delivery in terms of target coverage.PMID:37773941 | DOI:10.1080/0284186X.2023.2261621
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Sofie Tilb æk Stine Elleberg Petersen Liliana Stolarczyk Anne Vestergaard Heidi S R ønde Lise N Bentzen Jimmi S øndergaard Morten H øyer Ludvig Paul Muren Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | CT Scan | PET Scan | Prostate Cancer | Proton Therapy | Study